Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

inflammation · Mechanism Report

Can elevated CRP accompany high ferritin even when iron stores aren't increased?

Systemic inflammation raises ferritin as an acute-phase reactant and often causes ferritin to rise in parallel with C-reactive protein, independent of total-body iron stores.

PlausibleJune 19, 20269 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Ferritin is an acute-phase reactant that can rise with inflammation, and higher C-reactive protein can coincide with higher ferritin even when iron stores are not the only driver.

laying out figure…
2 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim reports that inflammation drives increases in both CRP and ferritin, so elevated ferritin can reflect inflammatory signaling rather than iron overload. Mechanistically, pro-inflammatory cytokine signaling induces acute-phase protein production and hepcidin-mediated iron sequestration, which together raise ferritin and confound interpretation of iron status.

Verified conclusion

Systemic inflammation significantly alters biomarkers used to evaluate iron status, making clinical interpretation challenging. Serum ferritin, while traditionally assessed as a marker of total-body iron stores, acts as a positive acute-phase reactant that rises in response to inflammatory signaling independently of iron status.

Clinical and effectiveness evidence

  • Co-elevation of biomarkers: Research consistently demonstrates a strong positive correlation between C-reactive protein (CRP) and serum ferritin. During systemic inflammation, both biomarkers rise in parallel, which can mimic or mask true iron disorders.
  • Diagnostic confounding: In patients with chronic inflammatory diseases or acute infections, elevated serum ferritin is frequently driven by inflammation rather than iron overload. Conversely, inflammation can artificially normalize ferritin levels in patients who actually have underlying iron deficiency.
  • Clinical utility of dual testing: Assessing CRP alongside ferritin is essential to contextualize iron panels. A elevated CRP (>5 mg/L) indicates that concurrent hyperferritinemia must be interpreted cautiously, often requiring additional markers like soluble transferrin receptor (sTfR) or transferrin saturation to accurately evaluate iron homeostasis.

Mechanistic explanations

  • Cytokine-mediated upregulation: Inflammatory stimuli trigger immune cells to release pro-inflammatory cytokines, specifically Interleukin-6 (IL-6). IL-6 acts directly on hepatocytes, binding to its receptor to initiate a signaling cascade that upregulates the transcription of acute-phase proteins.
  • Hepatic transcription of CRP: IL-6 signaling in the liver rapidly induces the transcription of CRP, which serves as a highly sensitive, direct marker of systemic inflammation.
  • The Hepcidin-Ferritin pathway: In parallel, IL-6 drives the hepatic production and secretion of hepcidin, the master iron-regulatory hormone. Hepcidin binds to the iron exporter ferroportin on macrophages and enterocytes, inducing its internalization and degradation. This traps iron inside the cells, and the resulting increase in intracellular iron triggers the synthesis and secretion of ferritin.

Bottom line

Serum ferritin is a highly sensitive acute-phase reactant that rises in tandem with C-reactive protein (CRP) during inflammatory states, driven by IL-6 and hepcidin-mediated iron sequestration. Consequently, when CRP is elevated, a high ferritin level does not reliably indicate iron overload and must be interpreted as a reflection of systemic inflammation.

References

  1. Eppur Si Muove: ferritin is essential in modulating inflammation — pmc.ncbi.nlm.nih.gov ↗
  2. Hyperferritinemia and inflammation — pmc.ncbi.nlm.nih.gov ↗
  3. Ferritin: An Inflammatory Player Keeping Iron at the Core of Pathogen-Host Interactions — pmc.ncbi.nlm.nih.gov ↗
  4. Optimal Serum Ferritin Level Range: iron status measure and inflammatory biomarker — pmc.ncbi.nlm.nih.gov ↗
  5. Epigallocatechin‐3‐gallate (EGCG) inhibits IL‐6‐induced CRP synthesis and ameliorates adiponectin expression in Hep3B cells — faseb.onlinelibrary.wiley.com ↗
  6. Mortality Risk in Pediatric Sepsis Based on C-reactive Protein and Ferritin Levels — pmc.ncbi.nlm.nih.gov ↗
  7. Iron overload as cardiovascular risk factor in children and adolescents with renal disease. — academic.oup.com ↗
  8. Serum ferritin/C-reactive protein ratio is a simple and effective biomarker for diagnosing iron deficiency in the context of systemic inflammation. — academic.oup.com ↗
  9. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan hs-CRP reflect low-grade systemic inflammation even within the normal range?→Plausible8 sourcesCan rs1420101 CT, rs20541 AG, and rs1801275 AG contribute to type 2 eosinophilic airway inflammation susceptibility?→